Skip to main content
. 2013 Feb 22;2(1):e003103. doi: 10.1161/JAHA.112.003103

Table 1.

Baseline Characteristics of Subjects Who Died, Had a Nonfatal ACS, or Did Not Have an Event Over the 16 Weeks of the Study (P Value From Kruskall–Wallis)

Death (n=127) Nonfatal ACS (n=348) No Event (n=2450) P Value
Age, mean (SD) 75 (10) 68 (12) 65 (12) <0.001
Male (%) 81 (64) 232 (67) 1591 (65) 0.81
Past MI (%) 56 (44) 114 (33) 558 (23) <0.001
Prior coronary revascularization 20 (16) 43 (12) 238 (10) 0.04
Hypertension (%) 82 (65) 184 (53) 1326 (54) 0.058
Current smoker (%) 14 (11) 81 (23) 723 (30) <0.001
Diabetes (%) 44 (35) 91 (26) 530 (22) <0.001
Body mass index (kg/m2), mean (SD) 26.9 (8.5) 27.4 (4.4) 27.6 (5.2) 0.052
Admission to randomization (h), mean (SD) 68 (45) 63 (23) 63 (23) 0.45
LVEF (%), median (25%, 75%)* 45 (33, 55) 50 (42, 61) 56 (47, 65) <0.001
Total cholesterol (mg/dL), mean (SD) 200 (48) 204 (41) 206 (37) 0.12
HDL (mg/dL), mean (SD) 45 (13) 45 (11) 47 (13) 0.002
LDL (mg/dL), mean (SD) 122 (40) 123 (34) 124 (33) 0.61
Triglycerides (mg/dL), mean (SD) 166 (69) 186 (83) 183 (92) 0.09
Troponin I, ng/mL (%) 64 (50) 140 (40) 1042 (43) 0.10
CRP (mg/L), median (25%, 75%) 20.1 (6.0, 52.9) 10.2 (4.5, 33.1) 10.2 (4.2, 35.0) 0.005
IL‐6 (pg/mL), median (25%, 75%) 10.8 (5.5, 20.8) 7.1 (3.7, 14.1) 6.7 (3.7, 14.6) <0.001
SAA (mg/dL), median (25%, 75%) 2.5 (0.7, 19.7) 1.4 (0.5, 8.6) 1.6 (0.6, 8.2) 0.02
VCAM (ng/L), median (25%, 75%) 959 (674, 1231) 870 (656, 1069) 808 (619, 1020) <0.001
ICAM (ng/L), median (25%, 75%) 307 (259, 366) 302 (263, 366) 299 (252, 358) 0.17
P‐Selectin (ng/L), median (25%, 75%) 65 (46, 96) 59 (42, 90) 59 (41, 93) 0.56
E‐Selectin (ng/L) median (25%, 75%) 47 (34, 63) 47 (33, 62) 48 (35, 62) 0.63
tPA (ng/L), median (25%, 75%) 15.1 (10.7, 24.3) 14.6 (9.6, 21.5) 13.5 (8.5, 20.3) 0.003

ACS indicates acute coronary syndrome; MI, myocardial infarction; LVEF, left ventricular ejection fraction; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; CRP, C‐reactive protein; IL‐6, interleukin‐6; SAA, serum amyloid A; VCAM, vascular cell adhesion molecule; ICAM, intercellular adhesion molecule; tPA, tissue plasminogen activator antigen.

*

LVEF measured in 910 subjects.